Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.50 contact hours for participating in this course.
DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).
Nurses will receive 1.50 contact hours for participating in this course.
Florida Board of Nursing CE Provider #: 50-290
Nurses will receive 1.50 contact hours for participating in this course.
Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Nurses will receive 1.50 contact hours for participating in this course.
Georgia Board of Nursing CE Provider #: 50-290
Nurses will receive 1.50 contact hours for participating in this course.
This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]
Outline:
Section 1: Introduction
A. About This Course
B. Learning Objectives
Section 2: Stroke Risk Factors and Prevalence
A. Glenn
B. Stroke Risks
C. Stroke Signs and Symptoms
D. Review
E. Summary
Section 3: Types of Strokes
A. What is a Stroke?
B. Ischemic Stroke
C. Hemorrhagic Stroke
D. Transient Ischemic Attack
E. Review
F. Summary
Section 4: Initial Assessment and Diagnostics for Strokes
A. The 8 D’s of Stroke Care
B. Immediate Assessment and Stabilization
C. FAST
D. Initial History
E. Neurological Assessment
F. Stroke Scales
G. Brain Imaging
H. General Physical Assessment
I. Laboratory Tests
J. Review
K. Summary
Section 5: Acute Ischemic Stroke Treatment and Management
A. Treatment Decisions for AIS
B. Alteplase (rtPA)
C. Management of Patients Receiving rtPA
D. Endovascular Therapy (EVT)
E. Post-EVT Management
F. General AIS Stroke Management
G. Placement of an ICP Monitoring Device
H. Decompressive Procedures
I. Review
J. Summary
Section 6: Hemorrhagic Stroke Treatment and Management
A. Primary Goal for Treatment and Management Decisions
B. Predicting Hematoma Growth
C. Preventing Hematoma Growth
D. Complications Following Acute ICH
E. Preventing Complications Following ICH
F. Review
G. Summary
Section 7: Conclusion
A. Summary
B. Course Contributors
C. References
Rebecca Smallwood, MBA, RN, has extensive experience across a wide spectrum of healthcare settings including: rural and urban acute care hospitals, public health, ambulatory surgery, higher education, and commercial healthcare learning organizations. Her roles have included: medical/surgical, ED, and OR staff and charge nurse; Director of School Health Services/school nurse; Public Health Epidemiology and Bioterrorism Preparedness Specialist; Infection control practitioner; Quality Management Specialist; Organizational Development Specialist; and Educator. Prior to joining Relias as a SME writer, she provided healthcare learning and development consultation to Swank Healthcare and was the Director of Education Services for Health.edu, a division of Texas Tech University Health Sciences Center. Rebecca earned a diploma in nursing from Methodist Hospital School of Nursing in Lubbock, Texas and an MBA from Wayland Baptist University. Disclosure: Rebecca Smallwood, MBA, RN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.